Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 935 of 1,261
  1. US 8110379

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  2. US 8109894

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  3. US 8110192

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  4. US 8110554

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  5. US 8110546

    VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  6. US 8110209

    Intracutaneous injection

    XERIS PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  7. US 2012029034

    Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

    AMMENDOLA ALDO [DE] · Granted Feb 2, 2012 · Expires Jan 28, 2032

    granted
  8. US 8106022

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  9. US 8106017

    Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same

    CAREGEN CO., LTD. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  10. US 8105607

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  11. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  12. US 8105264

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  13. US 8105263

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  14. US 8105262

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  15. US 8106160

    N-terminal modified interferon-alpha

    PHARMAESSENTIA CORPORATION · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  16. US 8106082

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  17. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  18. US 8106131

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  19. US 8106026

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  20. US 8105805

    High affinity human antibodies to human IL-18 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  21. US 8106027

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  22. US 8105626

    Granules containing acid-unstable chemical in large amount

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  23. US 8106087

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  24. US 8105598

    Human monoclonal antibodies that specifically bind IGF-II

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.